welcome to cyprotexcloe® screencloe® selectcloe® predict
home > about us > our vision

Our Vision

Cyprotex Discovery’s vision is to provide, in partnership with our customers in drug discovery and development, the highest quality, fastest turnaround and most cost-effective ADMET and pharmacokinetic data to the pharmaceutical industry.

As a pure service business, we aspire to be a leading edge technology business in the provision of ADMET screening services and in silico prediction to our customers which will translate into the discovery of more effective medicines. 

Our Ambition

• To exceed our customers' expectations in the provision of our services
• To maintain our position as the leading ADMET / PK outsourced service provider to the pharmaceutical industry
• To focus on our core deliverables of highly reproducible data in the fastest turnaround time and at the most cost–effective price to our customers
• To invest in and further develop our unique automated platform and information management systems
• To improve the recognition of the Cyprotex and Cyprotox brand worldwide
• To expand our customer base and deepen the relationships of our existing clients

request

Request a quotation or
one of our publications.

Quotation   Catalogue
ADME guide
contact

Contact us for more information on Cyprotex, including our extensive range of ADME/PK services
and pricing.

contact
careerscontactlegalprivacy
This website was last updated
on 29th July 2010
This website is intended to assist investors, industry participants, customers and employees to understand Cyprotex’s global operations and ambitions.
Certain information and detail is disclosed in the interest of compliance of AIM Rule 26.